Top Markets
#1 MarsCoin MarsCoin +46.67%
#2 Palladium Network Palladium Network +27.97%
#3 Siren Siren +27.76%
#4 Status Status +19.63%
#5 Useless Coin Useless Coin +18.72%
#6 Bedrock Bedrock +15.94%
#7 BankrCoin BankrCoin +15.33%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.19%
#9 Ankr Network Ankr Network +13.10%
#10 Arweave Arweave +10.04%
Coin of the day
MarsCoin MarsCoin
Settings
Language
ENGLISH
Currency
USD
Theme
NovaBridge Biosciences NovaBridge Biosciences

NovaBridge Biosciences

NBP
Rank in Stocks #18272
NovaBridge Biosciences, a biotechnology firm, primarily focuses on pioneering... NovaBridge Biosciences, a biotechnology firm, primarily focuses on pioneering immuno-oncology treatments for cancer patients within the United States. Its development pipeline features several significant drug candidates: givastomig, a bispecific antibody currently in Phase 1b clinical trials for gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, another bispecific antibody, which is undergoing Phase 1 clinical evaluation for solid tumors. The company maintains a strategic licensing agreement with Ferring International Center SA, encompassing the research, development, manufacturing, import, use, and commercialization rights for FE301, an interleukin-6 inhibitor. Additionally, NovaBridge Biosciences has established collaborations with Bristol Myers Squibb for givastomig's advancement, ABL Bio, Inc. for both givastomig and ragistomig, and TJ Bio for uliledlimab. Founded in 2014 and headquartered in Rockville, Maryland, the entity was formerly named I-Mab, with its transition to NovaBridge Biosciences slated for October 2025.
Share Price
$1.79
Last synced: 2026-09-02
Market Cap
$205.75M
Change (1 day)
3.18%
Change (1 year)
-61.61%
Country
US
Trade NovaBridge Biosciences (NBP)

Category

Healthcare
Stock price history for NovaBridge Biosciences (NBP)
Highest end of day price: $1.76 on 2026-09-01

Lowest end of day price: $13.69 on 2020-01-01
Stock price history of NovaBridge Biosciences from 2020 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -24.42%
2025 320.81%
2024 -37.56%
2023 -57.87%
2022 -92.59%
2021 24.83%
2020 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $556.43 40.29%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 45.39%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $152.82 535.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $123.39 -8.70%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $757.71 6.76%
CH